PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

Trump’s Campaign Website’s Only Drug Prices Policy Was Importation

If you care about and follow the issue of drug prices, then this week was bizarre on the political scene. In a press conference with Rep. Adam Schiff (D-CA) at her side, Speaker of the House Nancy Pelosi (D-CA) was imploring the media not to focus only on impeachment but on drug prices, noting that she believes Congress and President Trump can continue to work together despite the friction.

Yesterday, Trump was courting seniors in Florida, extolling drug price reductions under his watch that kind of, you know, never really happened and promising to save Medicare from “socialism” (go figure, Medicare is already a huge government program). Bizarrely, he implied that Big Pharma might have something to do with the impeachment inquiry against him. Maybe his Secretary of Health and Human Services, former Eli Lilly Pres. Alex Azar, is in on the “coup”… just joking. 

In the haze of the political circus, something fundamental keeps getting lost. During Trump’s 2016 campaign, the only policy he put forward on his website to bring down drug prices was drug importation. See below screenshot:

(more…)
Share
Tagged with: , ,

House Ways and Means Report Recommends Looking Abroad for Lower Drug Prices… Kind of…

A report (“A Painful Pill to Swallow: U.S. vs. International Prescription Drug Prices”) was released this week by the Congressional House Ways and Means Committee, showing that brand name drug prices are much lower – by about 75% on average – in other high-income countries. Who knew? Well, our analysis from this past summer showed that the average savings on popular brand drugs filled through online orders with Canadian pharmacies was 75%. When including pharmacies in other countries, the savings jumped to 90%. Those include pharmacies located in middle income countries, such as Turkey. For the record, these are comparisons among PharmacyChecker-accredited online pharmacies.

The committee’s report looked at prices of 79 brand name drugs in the following countries: Australia, Canada (specifically Ontario), Denmark, France, Germany, Japan, Netherlands, Portugal, Sweden, Switzerland, and the United Kingdom. I highly recommend reading this report if you want to learn about international drug price differentials and better understand how Americans are getting ripped off.

(more…)
Share
Tagged with: ,

Immigrants Buying Meds on the Street: A Problem of High Drug Prices and Fears of Deportation

A lot of media coverage about counterfeit drug threats in the U.S. are spurred by the media relations efforts of organizations funded by pharmaceutical companies, such as the Alliance for Safe Online Pharmacies and Partnership for Safe Medicines. As I see it, their public education efforts conflate safe online sales of medicines imported by consumers in the U.S. with counterfeit drug sales and other forms of drug sales, ones that clearly harm patients. One such article that did not fall prey to the propaganda was published in Kaiser Health News’ California Healthline detailing street market sales of prescription drugs, including cases that involve counterfeit drugs and the dangers they pose. Journalists who are looking closely, checking the funding of organizations disseminating information about prescription drug importation, can help stop the propaganda of the pharmaceutical industry.

The Kaiser story, written by John M. Glionna, focuses on Latino immigrant communities in which people can’t afford medication or, due to their immigration status, are fearful of deportation if they go to federally-funded clinics for medical treatments. Eight people were arrested and charged with illegal street sales of prescription drugs, including injectables and controlled drugs. Glionna describes the LA County authorities report:

(more…)
Share
Tagged with: , , ,

A Bittersweet Day: PharmacyChecker vs. Big Pharma

As I wrote a few weeks back, PharmacyChecker filed an antitrust lawsuit against five organizations that we believe are largely funded or backed by pharmaceutical companies. We allege that these organizations have conspired to illegally suppress competition in the areas of online pharmacy verification services and drug price comparisons on the Internet. The organizations are the National Association of Boards of Pharmacy (NABP), Alliance for Safe Online Pharmacies (ASOP), Partnership for Safe Medicines (PSM), LegitScript, and the Center for Safe Internet Pharmacies (CSIP).

As part of that suit, we filed a motion for preliminary injunction to immediately stop the NABP from including PharmacyChecker.com and this blogsite on its “Not Recommended Sites” list. That list was created to ostensibly identify rogue online pharmacies but has included safe international online pharmacies from its very inception. More recently NABP’s oversight has been expanded, apparently, to also include sites—such as this blog—that help consumers avoid rogue online pharmacies and find affordable drug prices!

(more…)
Share
Tagged with: , , , , ,

Top Economist Says the FDA Should be Identifying Safe Foreign Pharmacies to Solve High Drug Prices in America

Economics

Stephen Salant, PhD, professor emeritus of economics at the University of Michigan and research professor at the University of Maryland has written a paper that I believe gives voice and pays respect to the millions of Americans who import or are on the verge of importing lower-cost medication using online pharmacies. Let me be clear: this guy is a world-renowned economist. An expert in applied microeconomics, Professor Salant is most famous for his work in the economics of natural resources and industrial organization. Over the past few years, he has turned his attention to the problem of high drug prices in America and how to solve it without decreasing investment in research and development to create new life-saving drugs.

I’ll articulate the basic points of Salant’s paper, as I understand them, and then give some commentary.  

(more…)
Share
Tagged with: ,

Opioid Dealer Johnson & Johnson Fined $572 Mil for Contributing to 6,000 American Deaths

Johnson & Johnson Opioid Crisis

This week was a breakthrough for holding accountable the pharmaceutical industry for fueling the opioid crisis, which is responsible for approximately 400,000 deaths in the U.S. alone. In a landmark ruling, a judge in Oklahoma fined Johnson & Johnson $572 million for deceptive and aggressive marketing practices of opioid drugs that contributed to 6,000 deaths in that state. State prosecutors were successful by charging the drug company under laws relating to “public nuisances.” To remedy and remove the nuisance, the fine will go toward treatment, education and prevention programs related to opioid drugs. This resonates powerfully with me because, for years, I’ve observed how the drug industry abused the opioid crisis as a lobbying and public relations tool against prescription drug importation and to crack down against safe international online pharmacies, and even against PharmacyChecker. It has done so through its own trade associations and companies and by funding organizations to do their bidding.

(more…)
Share
Tagged with: , , , ,